Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections

Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections

US Patent 11261200 · Granted Mar 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted phenyloxazolidinones for antimicrobial therapy2024
Substituted phenyloxazolidinones for antimicrobial therapy2024
Substituted phenyloxazolidinones for antimicrobial therapy2020
Substituted phenyloxazolidinones for antimicrobial therapy2020
Cell penetrating peptides to target EIF4E2016
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof2012
Leukotriene B4 inhibitors2012
Chiral cis-imidazolines2011
MCH receptor antagonists2010
Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenase2010
Cis-imidazolines2010
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof2010